Editorial: Cardiac fibroblasts: from development to disease. [PDF]
Front Cell Dev BiolHernandez SC +2 more
europepmc +1 more source
Correction: Immunomodulatory potential of rapamycin-loaded mesoporous silica nanoparticles: pore size-dependent drug loading, release, and in vitro cellular responses. [PDF]
Drug Deliv Transl ResPérez-Moreno AM +4 more
europepmc +1 more source
Nanomedicinas: una alternativa terapéutica en desarrollo para el control de las crisis epilépticas
Argelia Rosillo-de la Torre +2 more
openalex +2 more sources
Advanced Immunoassays and Biosensing: From Design to Development. [PDF]
Biosensors (Basel)Li D, Wang X, Salvador JP.
europepmc +1 more source
La Nanomedicina en México: Normatividad y Empresas
, 2016 This research aims to analyze the implications of nanomedicine in Mexico. The incorporation of new technologies in health services represent a positive but no mechanical evolution in the social benefits in which they can bring. The production-structural change can not be sustained without full health.
openaire +1 more source
Correction: Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non‑small cell lung cancer based on real‑world data. [PDF]
Cancer Immunol ImmunotherRamos-Guerra AD +10 more
europepmc +1 more source
A nanomedicina lehetőségei és korlátai a stroke-on átesett betegek gyógykezelésében
Ferenc Bari +3 more
openalex +1 more source
Advances in New Alloys, Polymers and Composites for Biomedical Applications. [PDF]
Materials (Basel)Gil J +6 more
europepmc +1 more source